“That relationship is one of the greatest blessings and most important things in my life,” Common told podcast host Samantha Chatman in 2025 about what he’s built with fellow Oscar winner and partner, ...

The one thing that remains constant in the crypto market, irrespective of whether it's booming or not, is hacks. Thursday, hackers grabbed Bonk.fun's domain, the Raydium- and BONK-backed Solana token ...

GameSpot may get a commission from retail offers. When Barbarian and Weapons director Zach Cregger signed on to helm the next Resident Evil movie, it was described as "a revamp that will take the ...

More than 7,000 languages are spoken around the world today and at least 3,000 of them, or 40 percent, are endangered. English is the most widely spoken language, with approximately 1.5 billion ...

Add Yahoo as a preferred source to see more of our stories on Google. More than 7,000 languages are spoken around the world today and at least 3,000 of them, or 40 percent, are endangered. English is ...

A Chicago plumbers’ union is accusing Express Scripts Inc. of giving certain drugmakers preferential patient access in exchange for billions of dollars in rebates it withheld from the union health ...

The FTC first sued Express Scripts, CVS Caremark, and Optum in 2024, claiming anticompetitive and unfair rebating practices surrounding insulin. “Caremark, [Express Scripts], and Optum—as medication ...

Fraudsters significantly ramped up their use of AI to enhance campaigns across voice and virtual meeting channels last year, boosting speed and volume, according to Pindrop. The voice authentication ...

Cigna Corp's Express Scripts has settled the U.S. Federal Trade Commission's claims its insulin pricing practices violated antitrust and consumer protection laws, and agreed to changes aimed at ...

Express Scripts to change practices tied to high costs FTC to enforce 10-year settlement Deal requires company to work with local pharmacies Sign up here. "Our ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...